A PHASE 1 TRIAL OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) FOR THE TREATMENT OF NON-MUSCLE INVASIVE BCG UNRESPONSIVE UROTHELIAL CARCINOMA OF THE BLADDER

被引：0
|
作者：
DeCastro, G. Joel
Anderson, Christopher
Kates, Max
Buckley-Matura, Bridget
Sui, Wilson
Lee, Shing M.
Holder, Dara
Virk, Renu
Drake, Charles
Abate-Shen, Cory
McKiernan, James
机构：
来源：
JOURNAL OF UROLOGY | 2019年 / 201卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP43-14
引用
收藏
页码：E623 / E623
页数：1
相关论文
共 50 条
  • [1] A phase II trial of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) for the treatment of non-muscle invasive BCG unresponsive urothelial carcinoma of the bladder
    DeCastro, G. J.
    Stein, M.
    Abate-Shen, C.
    Miles, C.
    Gray, J.
    Joffe, B.
    Anderson, C.
    Lenis, A.
    McKiernan, J. M. M.
    ANNALS OF ONCOLOGY, 2024, 35 : S1143 - S1143
  • [2] Phase 2 trial of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) for the treatment of non-muscle invasive BCG unresponsive urothelial carcinoma of the bladder.
    DeCastro, Guarionex Joel
    Anderson, Christopher B.
    Abate-Shen, Cory
    Gray, Jillian
    Ingram, Justin
    Stein, Mark N.
    McKiernan, James M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    DeCastro, Guarionex
    Sui, Wilson
    Pak, Jamie
    Abate-Shen, Cory
    Lee, Shing
    Anderson, Christopher
    Holder, Dara
    McKiernan, James
    JOURNAL OF UROLOGY, 2017, 197 (04): : E175 - E176
  • [4] A phase I trial for the use of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) in the treatment of BCG-refractory nonmuscle invasive urothelial carcinoma of the bladder.
    DeCastro, Guarionex Joel
    Sui, Wilson
    Pak, Jamie S.
    Abate-Shen, Corinne T.
    Lee, Shing Mirn
    Anderson, Christopher B.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [5] COMBINATION REGIMEN OF INTRAVESICAL DOCETAXEL, GEMCITABINE, AND CISPLATIN IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Joffe, Benjamin I.
    Christin, John R.
    Le Coz, Clementine
    Pak, Jamie S.
    Laplaca, Caroline
    Reyes, Helena Vila
    DeCastro, G. Joel
    Anderson, Christopher B.
    Abate-Shen, Cory
    McKiernan, James M.
    Lenis, Andrew T.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E247 - E248
  • [6] A PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG-NA_IVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Patel, Sunil H.
    Gabrielson, Andrew T.
    Chan, Sin
    Schwartz, Deborah
    Collins, Connie
    Singla, Nirmish
    Trock, Bruce
    Bivalacqua, Trinity J.
    Hahn, Noah
    Kates, Max R.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E245 - E246
  • [7] Intravesical gemcitabine and docetaxel in the treatment of BCG-naive non-muscle invasive urothelial carcinoma of the bladder: Updates from a phase 2 trial.
    Patel, Sunil H.
    Gabrielson, Andrew
    Collins, Connie
    Singla, Nirmish
    Bivalacqua, Trinity
    Hahn, Noah M.
    Kates, Max R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [8] A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guerin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder
    DeCastro, Guarionex J.
    Sui, Wilson
    Pak, Jamie S.
    Lee, Shing M.
    Holder, Dara
    Kates, Max M.
    Virk, Renu K.
    Drake, Charles G.
    Anderson, Christopher B.
    James, Bridget
    Abate-Shen, Cory T.
    McKiernan, James M.
    JOURNAL OF UROLOGY, 2020, 204 (02): : 247 - 253
  • [9] INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG NA_IVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER: UPDATES FROM A PHASE 2 TRIAL
    Patel, Sunil
    Collins, Connie
    Singla, Nirmish
    Gabrielson, Andrew
    Bivalacqua, Trinity J.
    Hahn, Noah
    Kates, Max
    JOURNAL OF UROLOGY, 2022, 207 (05): : E1008 - E1008
  • [10] Hyperthermic intravesical chemotherapy for BCG unresponsive or BCG ineligible non-muscle invasive bladder cancer
    de Jong, Joep J.
    Rosier, Marloes
    Boormans, Joost L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 613 - 613
12345